| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | -100.0% |
| R&D Expense | $13.6M | -3.2% | +42.8% |
| SG&A Expense | $5.6M | +6.4% | +30.1% |
| Operating Income | -$19.2M | +0.6% | -49.3% |
| Pre-tax Income | -$30.6M | -47.5% | -233.0% |
| Income Tax | $11K | -31.3% | +178.6% |
| Net Income | -$30.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $27.0M | -36.2% | -67.1% |
| Short-term Investments | $84.7M | +19.3% | — |
| Current Assets | $113.8M | -1.2% | +32.2% |
| Total Assets | $125.1M | -1.2% | +27.1% |
| Current Liabilities | $8.0M | -13.9% | -86.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$37.2M | — | — |
| Investing Cash Flow | -$84.1M | — | — |
| Financing Cash Flow | $13.9M | — | — |
| -232.9% |
| EPS (Basic) | -$2.19 | -14.1% | -323.5% |
| EPS (Diluted) | -$2.19 | -14.1% | +22.6% |
| $33.6M |
| +52.5% |
| -55.7% |
| Stockholders' Equity | $91.5M | -12.5% | +334.4% |